Ken Nakatani

593 total citations
40 papers, 469 citations indexed

About

Ken Nakatani is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, Ken Nakatani has authored 40 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 9 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Ken Nakatani's work include Drug Transport and Resistance Mechanisms (4 papers), Stroke Rehabilitation and Recovery (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Ken Nakatani is often cited by papers focused on Drug Transport and Resistance Mechanisms (4 papers), Stroke Rehabilitation and Recovery (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Ken Nakatani collaborates with scholars based in Japan, Somalia and Finland. Ken Nakatani's co-authors include Shigeyuki Fujita, Takeshi Wada, Katsuhiro Uzawa, Hideki Tanzawa, Yukio Yamano, Megumi Nakamura, Kazuki Saito, Dai Nakashima, Atsushi Kasamatsu and Keiji Shinozuka and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Cancer.

In The Last Decade

Ken Nakatani

36 papers receiving 457 citations

Peers

Countries citing papers authored by Ken Nakatani

Since Specialization

Citations

This map shows the geographic impact of Ken Nakatani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Nakatani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Nakatani more than expected).

Fields of papers citing papers by Ken Nakatani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken Nakatani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Nakatani. The network helps show where Ken Nakatani may publish in the future.

Co-authorship network of co-authors of Ken Nakatani

This figure shows the co-authorship network connecting the top 25 collaborators of Ken Nakatani. A scholar is included among the top collaborators of Ken Nakatani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken Nakatani. Ken Nakatani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Translation of "Dysarthria" in Japanese 2023 ·The Japan Journal of Logopedics and Phoniatrics ·Noriko Nishizawa, (unknown), (unknown), (unknown), Yasuhiro Tanaka, Masahiro Nakamori, Ken Nakatani, (unknown), (unknown), Naohisa Hosomi, (unknown), Takashi Nakagawa	0
2	Mapping of susceptible variants for cold medicine-related Stevens–Johnson syndrome by whole-genome resequencing 2021 ·npj Genomic Medicine ·Yosuke Kawai, Yuki Hitomi, Mayumi Ueta, Seik‐Soon Khor, Ken Nakatani, Chie Sotozono, Shigeru Kinoshita, Masao Nagasaki, Katsushi Tokunaga	8
3	Evaluation of swallowing movement using ultrasonography 2019 ·Radiological Physics and Technology ·(unknown), (unknown), Ken Nakatani, (unknown)	16
4	NFKB1 and MANBA Confer Disease Susceptibility to Primary Biliary Cholangitis via Independent Putative Primary Functional Variants 2018 ·Cellular and Molecular Gastroenterology and Hepatology ·Yuki Hitomi, Ken Nakatani, Kaname Kojima, Nao Nishida, Yosuke Kawai, Minae Kawashima, Yoshihiro Aiba, Masao Nagasaki, Minoru Nakamura, Katsushi Tokunaga	18
5	Analysis of Causal Relationships by Structural Equation Modeling to Determine the Factors Influencing Cognitive Function in Elderly People in Japan 2015 ·PLoS ONE ·Daisuke Kimura, Ken Nakatani, Tokunori Takeda, Takashi Fujita, (unknown), Katsumi Inoue, (unknown)	5
6	A case of a penetrating stab wound with a branch of a tree entering the floor of the mouth from the submental region 2013 ·Japanese Journal of Oral & Maxillofacial Surgery ·Ken Nakatani, (unknown), Takeshi Wada, Shigeyuki Fujita	0
7	Horizontal visual search in a large field by patients with unilateral spatial neglect 2013 ·Journal of Clinical Neuroscience ·Ken Nakatani, (unknown), (unknown), Shusuke Takahashi, Katsumi Inoue	3
8	Relationship between language function and communicative ability of aphasics : the practical language abilities inferred from a SLTA test score 2013 ·Higher Brain Function Research ·(unknown), Masahiro Kanai, Ken Nakatani	0
9	Usefulness of Myofascial Flap Without Skin in Contemporary Oral and Maxillofacial Reconstruction 2011 ·Journal of Oral and Maxillofacial Surgery ·Takeshi Wada, Ken Nakatani, (unknown), (unknown), (unknown), Shigeyuki Fujita	6
10	Antitumor activity of satraplatin in cisplatin‐resistant oral squamous cell carcinoma cells 2010 ·Head & Neck ·Yukio Yamano, Masashi Shiiba, (unknown), Ken Nakatani, Atsushi Kasamatsu, Masanobu Yamatoji, (unknown), (unknown), Manabu Iyoda, Keiji Shinozuka, Hidetaka Yokoe, Takeshi Wada, Shigeyuki Fujita, Shunichiro Iwasawa, Yuichi Takiguchi, Hideki Tanzawa, Katsuhiro Uzawa	5
11	Identification of cisplatin‐resistance related genes in head and neck squamous cell carcinoma 2009 ·International Journal of Cancer ·Yukio Yamano, Katsuhiro Uzawa, Kazuki Saito, Dai Nakashima, Atsushi Kasamatsu, Hirofumi Koike, Yukinao Kouzu, Keiji Shinozuka, Ken Nakatani, (unknown), Shigeyuki Fujita, Hideki Tanzawa	80
12	EGFR Inhibitor Enhances Cisplatin Sensitivity of Oral Squamous Cell Carcinoma Cell Lines 2008 ·Pathology & Oncology Research ·(unknown), Takeshi Wada, Ken Nakatani, Itaru Tojyo, Takashi Matsumoto, (unknown), (unknown), Shigeyuki Fujita	40
13	Establishment and characterization of a cisplatin-resistant cell line, KB-R, derived from oral carcinoma cell line, KB 2007 ·International Journal of Oncology ·(unknown), Yukio Yamano, Kazuaki Fushimi, Kazuki Saito, Ken Nakatani, Masashi Shiiba, Hidetaka Yokoe, Hiroki Bukawa, Katsuhiro Uzawa, Takeshi Wada, Hideki Tanzawa, Shigeyuki Fujita	31
14	A case of metastatic carcinoma from a primary tumor of the submandibular gland (SqCC) to the sternoclavicular joint region successfully treated with concurrent chemotherapy (TPFL-Cepharanthine) and radiation therapy 2007 ·Toukeibu Gan ·Takeshi Wada, Ken Nakatani, (unknown), (unknown), (unknown), (unknown), Shigeyuki Fujita	0
15	CEPHARANTHIN ENHANCES CISPLATIN SENSITIVITY FOR CISPLATIN-RESISTANT ORAL SQUAMOUS CELL CARCINOMA CELL LINES 2006 ·Toukeibu Gan ·Ken Nakatani, Takeshi Wada, Takuya Tajima, (unknown), (unknown), (unknown), Shigeyuki Fujita	1
16	Vaginal Rhabdomyosarcoma in a Dog 2006 ·Veterinary Pathology ·Kazuhiko Suzuki, Ken Nakatani, Hiromi Shibuya, Takao Sato	14
17	Immunohistochemical expression of EGFR and p-EGFR in oral squamous cell carcinomas 2006 ·Pathology & Oncology Research ·(unknown), Takeshi Wada, Ken Nakatani, (unknown), Shigeyuki Fujita	56
18	Expression of caveolin-1 and its correlation with cisplatin sensitivity in oral squamous cell carcinoma 2005 ·Journal of Cancer Research and Clinical Oncology ·Ken Nakatani, Takeshi Wada, Megumi Nakamura, Katsuhiro Uzawa, Hideki Tanzawa, Shigeyuki Fujita	24
19	[Central nervous system metastasis from non-functioning adrenocortical carcinoma: report of a case]. 1997 ·PubMed ·Yukihiko Kubota, (unknown), Ken Nakatani, Naotaka Sakai, Akio Hara	5
20	Development of a subdural motor blockade 1993 ·Anaesthesia ·Fumio Asato, Ken Nakatani, (unknown), (unknown), (unknown)	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact